This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1998 Aug 8;352(9126):490.

doi: 10.1016/s0140-6736(05)79230-8.

Insulin-like growth factor-I and risk of breast cancer

J A Janssen, S W Lamberts

PMID: 9708785
DOI: 10.1016/s0140-6736(05)79230-8

Comment

Insulin-like growth factor-I and risk of breast cancer

J A Janssen et al. Lancet. 1998.

. 1998 Aug 8;352(9126):490.

doi: 10.1016/s0140-6736(05)79230-8.

Authors

J A Janssen, S W Lamberts

PMID: 9708785
DOI: 10.1016/s0140-6736(05)79230-8

No abstract available

PubMed Disclaimer

Comment in

Insulin-like growth factor-1 and risk of breast cancer.
Holly J. Holly J. Lancet. 1998 Oct 24;352(9137):1388. doi: 10.1016/S0140-6736(05)60781-7. Lancet. 1998. PMID: 9802298 No abstract available.

Comment on

Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.
Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M. Hankinson SE, et al. Lancet. 1998 May 9;351(9113):1393-6. doi: 10.1016/S0140-6736(97)10384-1. Lancet. 1998. PMID: 9593409

Similar articles

Insulin-like growth factor-1 and risk of breast cancer.
Holly J. Holly J. Lancet. 1998 Oct 24;352(9137):1388. doi: 10.1016/S0140-6736(05)60781-7. Lancet. 1998. PMID: 9802298 No abstract available.
Insulin-like growth factor-I and risk of breast cancer.
Strohm O, Osterziel KJ, Dietz R. Strohm O, et al. Lancet. 1998 Aug 8;352(9126):489. doi: 10.1016/s0140-6736(05)79227-8. Lancet. 1998. PMID: 9708783 No abstract available.
Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA, Borofsky ND, Massardo S, Orentreich N. Krajcik RA, et al. Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1566-73. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12496045
Acromegaly: re-thinking the cancer risk.
Loeper S, Ezzat S. Loeper S, et al. Rev Endocr Metab Disord. 2008 Mar;9(1):41-58. doi: 10.1007/s11154-007-9063-z. Rev Endocr Metab Disord. 2008. PMID: 18157698 Review.
The biochemical epidemiology of prostatic carcinoma.
Rose DP. Rose DP. Prog Clin Biol Res. 1986;222:43-68. Prog Clin Biol Res. 1986. PMID: 3097655 Review. No abstract available.

See all similar articles

Cited by

Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer.
Janssen JAMJL. Janssen JAMJL. Int J Mol Sci. 2021 Jul 21;22(15):7797. doi: 10.3390/ijms22157797. Int J Mol Sci. 2021. PMID: 34360563 Free PMC article. Review.
Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development.
Milani D, Carmichael JD, Welkowitz J, Ferris S, Reitz RE, Danoff A, Kleinberg DL. Milani D, et al. J Clin Endocrinol Metab. 2004 May;89(5):2271-4. doi: 10.1210/jc.2003-032150. J Clin Endocrinol Metab. 2004. PMID: 15126552 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information